Raw & starting materials quality, sourcing and management 2022

The living cell supply chain: a product-specific, rational approach to management of cellular starting material donors & donations

Cell & Gene Therapy Insights 2022; 8(10), 1375–1379

DOI: 10.18609/cgti.2022.201

Published: 18 November 2022
William E Janssen, Scott R. Burger

William E Janssen, WEJ Cell and Gene Therapy Consulting Services, & Scott R Burger, Advanced Cell and Gene Therapy, LLC

“In cell therapy and cell-based gene therapy products, donated, intact living cells are arguably the most critical of materials for CGT product manufacturing”